Á¦75Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1) : 2023-11-01
±³À°ÀÏÀÚ : 2023-11-01
±³À°Àå¼Ò : ¼¿ï COEX ºÏ¹® 103 ¿Ü
±³À°ÁÖÁ¦ : Á¦75Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1)
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190
À̸ÞÀÏ : urology@urology.or.kr
±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀÎ : 900¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 56ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í " # »çÀüµî·Ï ±âÁØ ¨çºÀÁ÷,°³¿øȸ¿ø:150,000¿ø ¨è±ºÀÇ°ü,°øº¸ÀÇ:80,000¿ø ¨éÀü°øÀÇ:80,000¿ø ¨êŸ°úÀü¹®ÀÇ:250,000¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 01ÀÏ 201È£ 09:00~09:40 What is preceptor role for urologist¡¯s ¾çÀº¹è(¿¬¼¼ÀÇ´ë ÀÇÇб³À°°ú)
±³À°½Ã°£ 11¿ù 01ÀÏ 201È£ 09:40~10:00 How to educate residents training in clinic ÇÏÁö¿ë(°è¸íÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 202+203È£ 10:00~10:30 ¼ö¼ú½Ç CCTV ¼³Ä¡ ¹ýÁ¦È¿¡ µû¸¥ ºñ´¢ÀÇÇаúÀÇ ´ëÃ¥ ¼ÛÇÊÇö(¿µ³²ÀÇ´ë) Çʼö
±³À°½Ã°£ 11¿ù 01ÀÏ 202+203È£ 10:30~11:00 ºñ´ë¸é Áø·á½Ã¹ü»ç¾÷¿¡ ´ëÇÑ ÀÇ·á¹ý Ãø¸é¿¡¼ÀÇ ºñ´¢ÀÇÇаú ´ëÃ¥ ±è¿¬ÁÖ(´ë±¸ÆÄƼ¸¶º´¿ø) Çʼö
±³À°½Ã°£ 11¿ù 01ÀÏ 202+203È£ 11:00~11:30 ºñ´¢ÀÇÇаú ¿µ¿ª¿¡¼ ÃÊ°í°¡ ºñ±Þ¿© ¼ú±â¿¡ ´ëÇÑ ±× ¹üÀ§¿Í À±¸®Àû ÀÚ¼¼ °¨¼ºÃ¶(°æ»óÀÇ´ë) Çʼö
±³À°½Ã°£ 11¿ù 01ÀÏ 202+203È£ 11:30~12:00 ºñ´¢ÀÇÇаú Àǻ簡 ¹Ù¶óº» °£È£»ç ÁعýÅõÀï ÃÖżö(°æÈñÀÇ´ë) Çʼö
½Ä»ç 11¿ù 01ÀÏ 12:00~13:00 ½Ä»ç ()
±âŸ 11¿ù 01ÀÏ 103È£ 13:00~13:04 clincally complete response in patient with MIBC after neoadjuvant chemotherapy: what is next? - Case presentation ³ëÅÂÀÏ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 13:04~13:17 clincally complete response in patient with MIBC after neoadjuvant chemotherapy: what is next? - Dadical cystectomy ¼È£°æ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 13:17~13:30 clincally complete response in patient with MIBC after neoadjuvant chemotherapy: what is next? - bladder preservation strategy ¼ºÇöȯ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 13:30~13:45 Optimizing combination therapies or therapeutic sequences for advanced or metastatic UC ÃÖÀ±Áö(°í·ÁÀÇ´ë Á¾¾ç³»°ú)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 13:45~14:00 Clinical usefulness of bladder MRI and VIRADS in bladder cancer. À±¼º±¹(µ¿¾ÆÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 14:00~14:15 Nerve sparing female cystectomy - robotic °¼®È£(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 14:15~14:30 Nerve sparing female cystectomy - open À̵¿Çö(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 14:30~14:45 Neobladder reconstruction in female cystectomy - robotic °¼®È£(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 14:45~15:00 Neobladder reconstruction in female cystectomy - open À̵¿Çö(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 15:00~15:30 Single port robotic partial nephrectomy - Retroperitoneal ±è±¤Çö(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 15:30~16:00 Single port robotic partial nephrectomy - Transperitoneal °í¿µÈÖ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 16:00~16:20 Surgical tips to manage various challenging situations at RARP ¹ÚÁø¼º(À»ÁöÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 16:20~16:40 RARP in patient with recurrent prostate cancer after radical prostatectomy ±èų²(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 11¿ù 01ÀÏ 103È£ 16:40~17:00 How to improve oncological outcomes in patients with T3 prostate cancer (wide excision) Á¶°¼ö(¿¬¼¼ÀÇ´ë)